Innovision Plus Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 21-12-2024
- Paid Up Capital ₹ 0.98 M
as on 21-12-2024
- Company Age 26 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.09 M
as on 21-12-2024
- Revenue -42.13%
(FY 2021)
- Profit 191.26%
(FY 2021)
- Ebitda -60.11%
(FY 2021)
- Net Worth 5.60%
(FY 2021)
- Total Assets 19.06%
(FY 2021)
About Innovision Plus
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.98 M.
The company currently has active open charges totaling ₹1.09 M.
Shalimar Indani, Simran Oswal, Sanjay Oswal, and Five other members serve as directors at the Company.
- CIN/LLPIN
U24231MH1998PTC113305
- Company No.
113305
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jan 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Innovision Plus?
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shalimar Indani  | Director | 03-Mar-2018 | Current |
| Sandeep Raka | Additional Director | 13-Mar-2020 | Current |
| Nikesh Oswal | Director | 18-Aug-2021 | Current |
| Simran Oswal | Director | 18-Aug-2021 | Current |
| Sanjay Oswal | Director | 18-Aug-2021 | Current |
| Priya Oswal | Director | 18-Aug-2021 | Current |
Financial Performance of Innovision Plus.
Innovision Plus Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 42.13% decrease. The company also saw a substantial improvement in profitability, with a 191.26% increase in profit. The company's net worth moved up by a moderate rise of 5.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Innovision Plus?
In 2020, Innovision Plus had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Shree Warana Sahakari Bank Ltd. Creation Date: 05 Mar 2004 | ₹0.30 M | Open |
Shree Warana Sahakari Bank Ltd. Creation Date: 12 Jan 2000 | ₹0.19 M | Open |
Shree Warana Sahakari Bank Ltd. Creation Date: 09 Dec 1999 | ₹0.30 M | Open |
How Many Employees Work at Innovision Plus?
Unlock and access historical data on people associated with Innovision Plus, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Innovision Plus, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innovision Plus's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
